Cargando…
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
Isoniazid (INH) is a first-line anti-tuberculosis drug used for nearly 70 years. However, the mechanism underlying the side effects of INH has remained elusive. Here, we report that INH and its metabolites induce a post-translational modification (PTM) of histones, lysine isonicotinylation (K(inic))...
Autores principales: | Jiang, Yuhan, Li, Yixiao, Liu, Cheng, Zhang, Lei, Lv, Danyu, Weng, Yejing, Cheng, Zhongyi, Chen, Xiangmei, Zhan, Jun, Zhang, Hongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452692/ https://www.ncbi.nlm.nih.gov/pubmed/34545082 http://dx.doi.org/10.1038/s41467-021-25867-y |
Ejemplares similares
-
Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011) -
Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012) -
Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008) -
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020) -
Predicting chromatin organization using histone marks
por: Huang, Jialiang, et al.
Publicado: (2015)